refenesen mucus relief

Generic: guaifenesin

Labeler: reese pharmaceutical co
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name refenesen mucus relief
Generic Name guaifenesin
Labeler reese pharmaceutical co
Dosage Form TABLET
Routes
ORAL
Active Ingredients

guaifenesin 400 mg/1

Manufacturer
Reese Pharmaceutical Co

Identifiers & Regulatory

Product NDC 10956-845
Product ID 10956-845_425102a9-bdd6-4b48-8758-503659b1b7b9
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M012
Listing Expiration 2026-12-31
Marketing Start 2021-04-15

Pharmacologic Class

Established (EPC)
expectorant [epc]
Physiologic Effect
decreased respiratory secretion viscosity [pe] increased respiratory secretions [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 10956845
Hyphenated Format 10956-845

Supplemental Identifiers

RxCUI
359601
UPC
0083513654151
UNII
495W7451VQ
NUI
N0000193956 N0000008867 N0000009560

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name refenesen mucus relief (source: ndc)
Generic Name guaifenesin (source: ndc)
Application Number M012 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (10956-845-30) / 30 TABLET in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

Ingredients (1)

guaifenesin (400 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "425102a9-bdd6-4b48-8758-503659b1b7b9", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0083513654151"], "unii": ["495W7451VQ"], "rxcui": ["359601"], "spl_set_id": ["861dffb7-8bf4-4f03-bcc2-ed8a35bc341d"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Reese Pharmaceutical Co"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (10956-845-30)  / 30 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "10956-845-30", "marketing_start_date": "20210415"}], "brand_name": "Refenesen Mucus Relief", "product_id": "10956-845_425102a9-bdd6-4b48-8758-503659b1b7b9", "dosage_form": "TABLET", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]"], "product_ndc": "10956-845", "generic_name": "Guaifenesin", "labeler_name": "Reese Pharmaceutical Co", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Refenesen Mucus Relief", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "400 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210415", "listing_expiration_date": "20261231"}